Spada Eva, Perego Roberta, Sgamma Elena Assunta, Proverbio Daniela
Department of Veterinary Medicine (DIMEVET), University of Milan, Via G. Celoria 10, 20133 Milan, Italy.
Department of Veterinary Medicine (DIMEVET), University of Milan, Via G. Celoria 10, 20133 Milan, Italy.
Prev Vet Med. 2018 Feb 1;150:38-46. doi: 10.1016/j.prevetmed.2017.12.001. Epub 2017 Dec 22.
Feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) are among the most important feline infectious diseases worldwide. This retrospective study investigated survival times and effects of selected predictor factors on survival time in a population of owned pet cats in Northern Italy testing positive for the presence of FIV antibodies and FeLV antigen. One hundred and three retrovirus-seropositive cats, 53 FIV-seropositive cats, 40 FeLV-seropositive cats, and 10 FIV+FeLV-seropositive cats were included in the study. A population of 103 retrovirus-seronegative age and sex-matched cats was selected. Survival time was calculated and compared between retrovirus-seronegative, FIV, FeLV and FIV+FeLV-seropositive cats using Kaplan-Meier survival analysis. Cox proportional-hazards regression analysis was used to study the effect of selected predictor factors (male gender, peripheral blood cytopenia as reduced red blood cells - RBC- count, leukopenia, neutropenia and lymphopenia, hypercreatininemia and reduced albumin to globulin ratio) on survival time in retrovirus-seropositive populations. Median survival times for seronegative cats, FIV, FeLV and FIV+FeLV-seropositive cats were 3960, 2040, 714 and 77days, respectively. Compared to retrovirus-seronegative cats median survival time was significantly lower (P<0.000) in FeLV and FIV+FeLV-seropositive cats. Median survival time in FeLV and FIV+FeLV-seropositive cats was also significant lower (P<0.000) when compared to FIV-seropositive cats. Hazard ratio of death in FeLV and FIV+FeLV-seropositive cats being respectively 3.4 and 7.4 times higher, in comparison to seronegative cats and 2.3 and 4.8 times higher in FeLV and FIV+FeLV-seropositive cats as compared to FIV-seropositive cats. A Cox proportional-hazards regression analysis showed that FIV and FeLV-seropositive cats with reduced RBC counts at time of diagnosis of seropositivity had significantly shorter survival times when compared to FIV and FeLV-seropositive cats with normal RBC counts at diagnosis. In summary, FIV-seropositive status did not significantly affect longevity of cats in this study, unlike FeLV and FIV+FeLV-seropositivity. Reduced RBC counts at time of FIV and FeLV diagnosis could impact negatively on the longevity of seropositive cats and therefore blood counts should always be evaluated at diagnosis and follow-up of retrovirus-seropositive cats.
猫免疫缺陷病毒(FIV)和猫白血病病毒(FeLV)是全球最重要的猫传染病之一。这项回顾性研究调查了意大利北部一群检测出FIV抗体和FeLV抗原呈阳性的宠物猫的生存时间以及选定预测因素对生存时间的影响。该研究纳入了103只逆转录病毒血清阳性猫,其中53只FIV血清阳性猫、40只FeLV血清阳性猫和10只FIV+FeLV血清阳性猫。选取了103只年龄和性别匹配的逆转录病毒血清阴性猫作为对照群体。使用Kaplan-Meier生存分析计算并比较了逆转录病毒血清阴性、FIV、FeLV和FIV+FeLV血清阳性猫的生存时间。采用Cox比例风险回归分析研究选定预测因素(雄性性别、外周血细胞减少,如红细胞计数减少、白细胞减少、中性粒细胞减少和淋巴细胞减少、血肌酐升高以及白蛋白与球蛋白比值降低)对逆转录病毒血清阳性群体生存时间的影响。血清阴性猫、FIV、FeLV和FIV+FeLV血清阳性猫的中位生存时间分别为3960天、2040天、714天和77天。与逆转录病毒血清阴性猫相比,FeLV和FIV+FeLV血清阳性猫的中位生存时间显著缩短(P<0.000)。与FIV血清阳性猫相比,FeLV和FIV+FeLV血清阳性猫的中位生存时间也显著缩短(P<0.000)。FeLV和FIV+FeLV血清阳性猫的死亡风险比分别比血清阴性猫高3.4倍和7.4倍,比FIV血清阳性猫高2.3倍和4.8倍。Cox比例风险回归分析表明,与诊断时红细胞计数正常的FIV和FeLV血清阳性猫相比,诊断时血清呈阳性且红细胞计数减少的FIV和FeLV血清阳性猫的生存时间显著缩短。总之,与FeLV和FIV+FeLV血清阳性不同,FIV血清阳性状态在本研究中并未显著影响猫的寿命。FIV和FeLV诊断时红细胞计数减少可能会对血清阳性猫的寿命产生负面影响,因此在逆转录病毒血清阳性猫的诊断和随访中应始终评估血细胞计数。